Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective 01 September 2022
Solactive China Healthcare Disruption Index:
In the ordinary rebalancing effective open September 01, 2022 the following index composition was implemented:
| 3SBIO INC | 0.8389% |
| AKESO INC | 1.2537% |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 4.1492% |
| ANGELALIGN TECHNOLOGY INC | 1.6471% |
| CANSINO BIOLOGICS INC | 2.3512% |
| CARSGEN THERAPEUTICS HOLDING | 0.7218% |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 2.0811% |
| CLOUDR GROUP LTD | 0.6905% |
| CSPC PHARMACEUTICAL GROUP LTD | 6.5195% |
| GENSCRIPT BIOTECH CORP | 3.9496% |
| GRAND PHARMACEUTICAL GROUP LTD | 1.0199% |
| GUSHENGTANG HOLDINGS LTD | 0.5859% |
| HANSOH PHARMACEUTICAL GROUP CO | 6.0078% |
| INNOCARE PHARMA LTD | 1.1733% |
| INNOVENT BIOLOGICS INC | 3.4718% |
| JD HEALTH INTERNATIONAL INC | 8.0000% |
| JOINN LABORATORIES CHINA C-H | 3.1749% |
| KEYMED BIOSCIENCES INC | 0.5726% |
| LIFETECH SCIENTIFIC CORP | 0.7432% |
| LUYE PHARMA GROUP LTD | 0.5507% |
| MICROPORT NEUROTECH LTD | 0.9609% |
| MICROPORT SCIENTIFIC CORP | 2.2323% |
| NEW HORIZON HEALTH LTD | 0.6884% |
| PING AN HEALTHCARE AND TECHNOL | 1.5002% |
| REMEGEN CO LTD-H | 2.2372% |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD | 2.9160% |
| SHANGHAI BIO-HEART BIOLOGI-H | 1.1180% |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 8.0000% |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 3.7159% |
| SHANGHAI MICROPORT MEDBOT GR | 1.8782% |
| SIMCERE PHARMACEUTICAL GROUP | 1.4550% |
| SINO BIOPHARMACEUTICAL LTD ORD | 5.4442% |
| WUXI APPTEC CO LTD | 8.0000% |
| WUXI BIOLOGICS CAYMAN INC | 8.0000% |
| ZAI LAB LTD | 2.3509% |